Zenas BioPharma, Inc.

NASDAQ:ZBIO

Biotechnology

Healthcare
$25.04 +3.46%

+$0.64 today

Market cap
$1.70B
Beta
-0.69
P/E (TTM)
-2.5
EPS (TTM)
-$7.64
52W Low $8.91High $44.60

Volume 0.27M

Average 0.71M

Balance Sheet

Inspect the capital base behind the business.

Assets

$383.64M

FY 2025 · Annual

+3.7% YoY

Liabilities

$141.50M

FY 2025 · Annual

+146.0% YoY

Equity

$242.14M

FY 2025 · Annual

-22.5% YoY

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents67.21M56.86M319.74M110.64M
Short-term Investments0031.02M232.55M
Net Receivables0000
Inventory0000
Other Current Assets1.24M2.95M5.16M7.98M
Total Current Assets68.44M59.8M355.92M351.17M
Property, Plant & Equipment (Net)1.8M1.01M1.19M1.39M
Goodwill0000
Intangible Assets0000
Long-term Investments00017.27M
Tax Assets0000
Other Non-current Assets4.33M7.36M12.86M13.81M
Total Non-current Assets6.14M8.38M14.05M32.47M
Total Assets74.58M68.18M369.97M383.64M
Account Payables5.82M5.4M17.14M7.11M
Short-term Debt0001.12M
Tax Payables0301K211K0
Deferred Revenue0000
Other Current Liabilities4.33M5.12M8.31M41.23M
Total Current Liabilities25.97M23.26M57.29M62.65M
Long-term Debt020.3M078.64M
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities240.09M250.09M00
Total Non-current Liabilities240.9M270.64M218K78.85M
Total Liabilities266.87M293.9M57.51M141.5M
Common Stock004K5K
Retained Earnings(193.28M)(230.4M)(387.39M)(765.13M)
Accumulated OCI(41K)37K194K(64K)
Other Stockholders Equity0000
Minority Interest0000
Total Equity(192.29M)(225.72M)312.46M242.14M
Total Debt1.53M21.11M1M79.96M
Net Debt(65.68M)(35.74M)(318.74M)(30.68M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$500.2M
Short-term Investments$217.0M
Receivables$1.1M
Other Current$11.9M
Total Current Assets$730.2M
PP&E (Net)$1.1M
Long-term Investments$1.3M
Other Non-current$15.1M
Total Non-current Assets$17.5M
Total Assets$747.7M

Analysis

Selected assets total $747.7M for Latest. The largest visible component is Cash & Equivalents at $500.2M, about 66.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 6, 2026
424B5424B5 filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026

How much cash does ZBIO have?

Zenas BioPharma, Inc. (ZBIO) reported $110.64M in cash and equivalents in fiscal 2025.

How much debt does ZBIO carry?

Zenas BioPharma, Inc. (ZBIO) reported $79.96M of total debt, with net debt of -$30.68M.